FK866 hydrochloride hydrate
SIGMA/F8557 - ≥98% (HPLC)
Synonym: FK866 hydrochloride hydrate; (E)
CAS Number: 658084-64-1 (free base)
Empirical Formula (Hill Notation): C24H29N3O2·HCl · xH2O
Molecular Weight: 427.97 (anhydrous basis)
MDL Number: MFCD10565943
Linear Formula: C24H29N3O2·HCl · xH2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C24H29N3O2/c28-23(12-1 |
| InChI key | KPBNHDGDUADAGP-VAWYXSNFSA |
| Quality Level | 100 ![]() |
| SMILES string | N2(CCC(CC2)CCCCNC(=O)C=C |
| solubility | DMSO: 10 mg/mL, clear |
| storage condition | desiccated |
| storage temp. | −20°C |
| Application: | FK866 hydrochloride hydrate has been used: • to investigate its effects on intra-axonal NAD+ levels • to induce NAD+ depletion • to reduce the level of tumor necrosis factor-α (TNF-α), nicotinamide phosphoribosyltransferase (NAMPT) and interleukin-6 (IL-6) in the ischemic brain tissue |
| Biochem/physiol Actions: | FK866 is a potent inhibitor of NAD biosynthesis, and a specific inhibitor of NAMPT (Nicotinamide Phosphoribosyltransferase |
| Biochem/physiol Actions: | FK866 is a potent inhibitor of NAD biosynthesis. |
| General description: | FK866 is used to treat inflammatory diseases and cancer. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 51111800 |


